The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Ojewunmi OO., Adeyemo TA., Oyetunji AI., Inyang B., Akinrindoye A., Mkumbe BS., Gardner K., Rooks H., Brewin J., Patel H., Lee SH., Chung R., Rashkin S., Kang G., Chianumba R., Sangeda R., Mwita L., Isa H., Agumadu U-N., Ekong R., Faruk JA., Jamoh BY., Adebiyi NM., Umar IA., Hassan A., Grace C., Goel A., Inusa BPD., Falchi M., Nkya S., Makani J., Ahmad HR., Nnodu O., Strouboulis J., Menzel S.
The clinical severity of sickle cell disease (SCD) is strongly influenced by the level of fetal haemoglobin (HbF) persistent in each patient. Three major HbF loci (BCL11A, HBS1L-MYB, and Xmn1-HBG2) have been reported, but a considerable hidden heritability remains. We conducted a genome-wide association study for HbF levels in 1006 Nigerian patients with SCD (HbSS/HbSβ0), followed by a replication and meta-analysis exercise in four independent SCD cohorts (3,582 patients). To dissect association signals at the major loci, we performed stepwise conditional and haplotype association analyses and included public functional annotation datasets. Association signals were detected for BCL11A (lead SNP rs6706648, β = -0.39, P = 4.96 × 10-34) and HBS1L-MYB (lead SNP rs61028892, β = 0.73, P = 1.18 × 10-9), whereas the variant allele for Xmn1-HBG2 was found to be very rare. In addition, we detected three putative new trait-associated regions. Genetically, dissecting the two major loci BCL11A and HBS1L-MYB, we defined trait-increasing haplotypes (P